m+Medelevator.RU
← Поиск публикаций
Nature communications · 2025

Early genetic evolution of driver mutations in uveal melanoma.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Dollar James J, Decatur Christina L, Weis Ezekiel, Schefler Amy C, Materin Miguel A, Fuller Timothy S, Skalet Alison H, Reichstein David A, Kim Ivana K, Piggott Kisha D, Demirci Hakan, Aaberg Thomas A, Mruthyunjaya Prithvi, Williams Basil K, Shildkrot Eugene, Oliver Scott C N, Char Devron H, Capone Antonio, Mason John O, Walter Scott D, Altaweel Michael M, Wells Jill R, Gombos Dan S, Duker Jay S, Hovland Peter G, Tsai Tony, Javid Cameron, Durante Michael A, Covington Kyle R, Zhang Song, Correa Zelia M, Harbour J William

Аннотация

Uveal melanoma (UM) is an aggressive eye cancer that frequently results in metastatic death despite successful primary tumor treatment. Subclinical micrometastasis is thought to occur early, when tumors are small and difficult to distinguish from benign nevi. However, the early genetic evolution of UM is poorly understood, and biomarkers for malignant transformation are lacking. Here, we perform integrated genetic profiling of 1140 primary UMs, including 131 small tumors. A clinically available 15-gene expression profile (15-GEP) prospectively validated by our group is more accurate than driver mutations for predicting patient survival. Small tumors are significantly more likely to be in earlier stages of genetic evolution than larger tumors. Further, the 15-GEP support vector machine discriminant score predicts small tumors undergoing transformation from low-risk Class 1 to high-risk Class 2 profile. These results shed light on the early genetic evolution of UM and move us closer to a molecular definition of malignant transformation in this cancer type.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты